MFUSE

Uncontrolled Post-Traumatic Hemorrhage

Pre-clinicalActive

Key Facts

Indication
Uncontrolled Post-Traumatic Hemorrhage
Phase
Pre-clinical
Status
Active
Company

About Machina Medical

Machina Medical is a private, pre-revenue medical device company focused on addressing uncontrolled post-traumatic hemorrhage, a leading cause of preventable death in both military and civilian settings. The company's core innovation is the MFUSE technology, a next-generation hemostatic wound care solution designed for use by military personnel, first responders, and in trauma centers. Operating in the stagnant hemostatic agent market, Machina aims to challenge decades-old foundational science with a novel approach, positioning itself to capture significant share in a large and critical global market.

View full company profile